Trade CRVO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
CervoMed Inc. (CRVO) is trading at US$2.43, down 4.71% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$39.61M. Over the past 52 weeks, CRVO has traded between US$2.13 and US$10.00. On Syfe you can trade CRVO with $0 commission and add it to your watchlist.
| Previous close | US$2.55 |
|---|---|
| Market cap | US$39.61M |
| 52-week range | US$2.13 – US$10.00 |
| Volume | 179.11K |
| Exchange | US |
Add to Watchlist
Set Price Alert
CervoMed Inc.
CervoMed, Inc. is a clinical stage biotechnology company. It engages in the business of advancing CNS focused therapeutics to benefit patients with a range of degenerative diseases of the brain. The company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant that inhibits p38MAP kinase alpha. CervoMed, Inc. was founded in1995 and is headquartered in Boston, MA.
Year: 1996
CervoMed Completes Enrollment in Phase 2a Study of Neflamapimod in Frontotemporal Dementia
Jul 9, 12:06 PM · MT Newswires
CervoMed Files for Resale of Common Shares
Jul 6, 9:39 PM · MT Newswires
CervoMed Closes $10 Million Stock Offering
Jun 22, 9:38 PM · MT Newswires
Top Midday Gainers
Jun 18, 5:32 PM · MT Newswires
CervoMed Reports $10 Million Direct Offering of Shares
Jun 18, 4:52 PM · MT Newswires
CervoMed Inc. (CRVO) stock is trading at US$2.43, -4.71% from the previous close of US$2.55.
The market cap for CervoMed Inc. (CRVO) stock is approximately US$39.61M.
The 52-week high for CervoMed Inc. (CRVO) stock is US$10.00.
The 52-week low for CervoMed Inc. (CRVO) stock is US$2.13.
CervoMed Inc. (CRVO) does not currently pay a dividend.
Stay on top of CRVO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
